These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28202175)

  • 1. Charytan DM, Desai M, Mathur M, et al. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016;90:411-421.
    Kidney Int; 2017 Mar; 91(3):758. PubMed ID: 28202175
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
    Charytan DM; Desai M; Mathur M; Stern NM; Brooks MM; Krzych LJ; Schuler GC; Kaehler J; Rodriguez-Granillo AM; Hueb W; Reeves BC; Thiele H; Rodriguez AE; Buszman PP; Buszman PE; Maurer R; Winkelmayer WC
    Kidney Int; 2016 Aug; 90(2):411-421. PubMed ID: 27259368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease.
    Volodarskiy A; Kumar S; Amin S; Bangalore S
    Am J Med; 2016 Dec; 129(12):1288-1298. PubMed ID: 27476086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revascularization options in patients with chronic kidney disease.
    Ashrith G; Elayda MA; Wilson JM
    Tex Heart Inst J; 2010; 37(1):9-18. PubMed ID: 20200622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
    Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
    Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention?
    Castelvecchio S; Menicanti L; Garatti A; Tramarin R; Volpe M; Parolari A
    Ann Thorac Surg; 2016 Sep; 102(3):1012-1022. PubMed ID: 27217297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
    Aronson D; Edelman ER
    Rev Endocr Metab Disord; 2010 Mar; 11(1):75-86. PubMed ID: 20221852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedure rates and outcomes of coronary revascularization procedures in California and New York.
    Carey JS; Danielsen B; Gold JP; Rossiter SJ
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1276-82. PubMed ID: 15942567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid coronary revascularization in the era of drug-eluting stents.
    Murphy GJ; Bryan AJ; Angelini GD
    Ann Thorac Surg; 2004 Nov; 78(5):1861-7. PubMed ID: 15511503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery.
    Thielmann M; Massoudy P; Jaeger BR; Neuhäuser M; Marggraf G; Sack S; Erbel R; Jakob H
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):117-25. PubMed ID: 16723243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results.
    Nicolini F; Contini GA; Fortuna D; Pacini D; Gabbieri D; Vignali L; Campo G; Manari A; Zussa C; Guastaroba P; De Palma R; Gherli T
    Ann Thorac Surg; 2015 Feb; 99(2):567-74. PubMed ID: 25499479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?
    Ferguson TB; Chen C; Babb JD; Efird JT; Daggubati R; Cahill JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):824-835.e1. PubMed ID: 23915918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.
    Lautamäki A; Kiviniemi T; Biancari F; Airaksinen J; Juvonen T; Gunn J
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):926-30. PubMed ID: 26142469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.